Savolitinib found to help treatment-resistant lung cancer in combo with AZ’s Tagrisso
The news was announced at the American Association for Cancer Research (AACR) annual meeting.
Read More
Tag: Savolitinib
AstraZeneca’s Imfinzi gets speedy US review for lung cancer
US regulators have accepted an application by AstraZeneca and MedImmune to expand the scope of Imfinzi to include patients with a certain form of lung cancer.
Read More
AZ, Chi-Med test savolitinib in kidney cancer
AstraZeneca and Hutchison China MediTech (Chi-Med) have begun trialling savolitinib in patients with a particular type of kidney cancer in a global, open-label, randomised Phase III registration study
Read More
- MHRA to open new Northern Ireland hub to strengthen UK‑wide life sciences collaboration
- Novo Nordisk data shows oral semaglutide delivers significant weight loss in phase 3 trial
- Enterprise reports positive phase 2 data for inhaled ENaC blocker in cystic fibrosis
- SMC backs first-line metastatic bladder cancer combination after trial results
- Poolbeg secures Canadian patent for POLB 001 in cancer immunotherapy‑induced CRS
